These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 29804556)
1. Up-regulation of HOXB cluster genes are epigenetically regulated in tamoxifen-resistant MCF7 breast cancer cells. Yang S; Lee JY; Hur H; Oh JH; Kim MH BMB Rep; 2018 Sep; 51(9):450-455. PubMed ID: 29804556 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells. Men X; Su M; Ma J; Mou Y; Dai P; Chen C; Cheng XA Technol Cancer Res Treat; 2021; 20():15330338211004916. PubMed ID: 33745390 [TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer. Guney Eskiler G; Cecener G; Dikmen G; Egeli U; Tunca B Eur J Pharm Sci; 2018 Jul; 120():73-88. PubMed ID: 29719240 [TBL] [Abstract][Full Text] [Related]
4. Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer. Giannoudis A; Malki MI; Rudraraju B; Mohhamed H; Menon S; Liloglou T; Ali S; Carroll JS; Palmieri C Breast Cancer Res; 2020 Nov; 22(1):126. PubMed ID: 33198803 [TBL] [Abstract][Full Text] [Related]
5. Expression of the CD59 Glycoprotein Precursor is Upregulated in an Estrogen Receptor-alpha (ER-α)-Negative and a Tamoxifen-Resistant Breast Cancer Cell Line In Vitro. Xiong H; Jin X; You C Med Sci Monit; 2018 Nov; 24():7883-7890. PubMed ID: 30391994 [TBL] [Abstract][Full Text] [Related]
6. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer. Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905 [TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells. Li G; Zhang J; Jin K; He K; Zheng Y; Xu X; Wang H; Wang H; Li Z; Yu X; Teng X; Cao J; Teng L Mol Oncol; 2013 Jun; 7(3):611-24. PubMed ID: 23499324 [TBL] [Abstract][Full Text] [Related]
8. Cold atmospheric plasma restores tamoxifen sensitivity in resistant MCF-7 breast cancer cell. Lee S; Lee H; Jeong D; Ham J; Park S; Choi EH; Kim SJ Free Radic Biol Med; 2017 Sep; 110():280-290. PubMed ID: 28666851 [TBL] [Abstract][Full Text] [Related]
9. Modulation of BAG-1 expression alters the sensitivity of breast cancer cells to tamoxifen. Liu H; Lu S; Gu L; Gao Y; Wang T; Zhao J; Rao J; Chen J; Hao X; Tang SC Cell Physiol Biochem; 2014; 33(2):365-74. PubMed ID: 24557447 [TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity. Zhang X; Wang ZY Endocrinology; 2013 Jun; 154(6):1990-8. PubMed ID: 23546601 [TBL] [Abstract][Full Text] [Related]
11. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells. Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106 [TBL] [Abstract][Full Text] [Related]
12. CUL4B renders breast cancer cells tamoxifen-resistant via miR-32-5p/ER-α36 axis. Wang Y; Pan X; Li Y; Wang R; Yang Y; Jiang B; Sun G; Shao C; Wang M; Gong Y J Pathol; 2021 Jun; 254(2):185-198. PubMed ID: 33638154 [TBL] [Abstract][Full Text] [Related]
13. [Involvement of epidermal growth factor receptor signaling pathway in tamoxifen resistance of MCF-7 cells]. Zhen LL; Zhu X; Zheng W; Wang XY; Wu ZY Ai Zheng; 2006 Jul; 25(7):839-43. PubMed ID: 16831274 [TBL] [Abstract][Full Text] [Related]
14. Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation. Guest SK; Ribas R; Pancholi S; Nikitorowicz-Buniak J; Simigdala N; Dowsett M; Johnston SR; Martin LA PLoS One; 2016; 11(6):e0157397. PubMed ID: 27308830 [TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer. Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162 [TBL] [Abstract][Full Text] [Related]
16. Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer. Liu B; Wang T; Wang H; Zhang L; Xu F; Fang R; Li L; Cai X; Wu Y; Zhang W; Ye L J Hematol Oncol; 2018 Feb; 11(1):26. PubMed ID: 29471853 [TBL] [Abstract][Full Text] [Related]
17. Overexpression miR-24-3p repressed Bim expression to confer tamoxifen resistance in breast cancer. Han X; Li Q; Liu C; Wang C; Li Y J Cell Biochem; 2019 Aug; 120(8):12966-12976. PubMed ID: 31001849 [TBL] [Abstract][Full Text] [Related]
18. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells. Li Z; Wang N; Fang J; Huang J; Tian F; Li C; Xie F Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054 [TBL] [Abstract][Full Text] [Related]
19. Tamoxifen-resistant breast cancer cells possess cancer stem-like cell properties. Liu H; Zhang HW; Sun XF; Guo XH; He YN; Cui SD; Fan QX Chin Med J (Engl); 2013 Aug; 126(16):3030-4. PubMed ID: 23981606 [TBL] [Abstract][Full Text] [Related]
20. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells. Phuong NT; Kim SK; Lim SC; Kim HS; Kim TH; Lee KY; Ahn SG; Yoon JH; Kang KW Breast Cancer Res Treat; 2011 Nov; 130(1):73-83. PubMed ID: 21170675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]